XRTXF - XORTX Therapeutics Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
2/27/2017
12/30/2016
2/28/2016
Total Revenue
0
0
0
-
0
-
Cost of Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Expenses
Research Development
190
342
66
-
0
-
Selling General and Administrative
489
796
381
194
389
205
Total Operating Expenses
698
1,157
464
194
405
205
Operating Income or Loss
-698
-1,157
-464
-194
-405
-205
Interest Expense
29
22
15
-
9
-
Total Other Income/Expenses Net
-35
-2,596
5
-231
-1
0
Income Before Tax
-763
-3,776
-474
-424
-415
-205
Income Tax Expense
-
-
-
-
-
-
Income from Continuing Operations
-763
-3,776
-474
-424
-415
-205
Net Income
-763
-3,776
-474
-424
-415
-205
Net Income available to common shareholders
-763
-3,776
-474
-424
-415
-205
Reported EPS
Basic
-
-0.06
-0.02
-0.03
-0.02
-0.02
Diluted
-
-0.06
-0.02
-0.03
-0.02
-0.02
Weighted average shares outstanding
Basic
-
61,816
22,344
16,631
21,424
12,311
Diluted
-
61,816
22,344
16,631
21,424
12,311
EBITDA
-
-3,734
-442
-194
-390
-205